Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

MD Anderson, C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

MD Anderson Cancer Center and C-Biomex Ltd. have formed a strategic research collaboration agreement to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.

February 16, 2024

Vol.50 No.07

In Brief

MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine

MD Anderson Cancer Center has signed an agreement with the International Atomic Energy Agency to become an IAEA Collaborating Centre.

February 02, 2024

Vol.50 No.05

Obituary

Cullen Taniguchi, radiation oncologist at MD Anderson, dies at 47

We unexpectedly lost a dear friend and colleague, Dr. Cullen Taniguchi, in mid-November. Dr. Taniguchi was an exceptional and compassionate clinician, brilliant scientist, and nurturing mentor. Above all, he was a dedicated and loving husband, father, son, and brother. We deeply mourn his loss, but we forever cherish the memories and indelible legacy that he leaves with us.

For cancer patients, traditional Medicare is better than Medicare Advantage

Now that the Medicare re-enrollment period has arrived (Oct. 15-Dec. 7), senior Americans are exposed to ubiquitous advertisements, phone calls, and other mechanisms to convince them to enroll in Medicare Advantage rather than traditional Medicare plans.

December 01, 2023

Vol.49 No.44

By Hagop M. Kantarjian and Mary Alma Welch

In Brief

MD Anderson receives $25M to establish Meyers Institute for Oncology Nursing

Howard Meyers, of Dallas, Texas, a member of The University of Texas MD Anderson Cancer Center Board of Visitors, has donated $25 million to MD Anderson Cancer Center to establish the Meyers Institute for Oncology Nursing.

November 17, 2023

Vol.49 No.43

In Brief

MD Anderson establishes Institute for Data Science in Oncology

MD Anderson Cancer Center launched its Institute for Data Science in Oncology, or IDSO, which integrates the most advanced computational and data science approaches with the institution’s extensive scientific and clinical expertise to significantly improve patient’s lives by transforming cancer care and research.

November 10, 2023

Vol.49 No.42

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

YOU MAY BE INTERESTED IN

MD Anderson, C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

MD Anderson designated IAEA Collaborating Centre to focus on improving radiation, radiology and nuclear medicine

Cullen Taniguchi, radiation oncologist at MD Anderson, dies at 47

For cancer patients, traditional Medicare is better than Medicare Advantage

MD Anderson receives $25M to establish Meyers Institute for Oncology Nursing

MD Anderson establishes Institute for Data Science in Oncology

Renew today!

Subscriber content

Login